SCHEMBL5221253

SCHEMBL5221253

O=C(O)Nc1ccc(N2CCSCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.51
ALDH1A1 P00352 7/20 0.51
KDM4E B2RXH2 4/20 0.51
KMT2A Q03164 4/20 0.51
GAA P10253 3/20 0.51
MEN1 O00255 3/20 0.51
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
NPSR1 Q6W5P4 4/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
PKM P14618 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
GFER P55789 1/20 0.50
SMN1; SMN2 Q16637 6/20 0.49
TP53 P04637 2/20 0.49
GLA P06280 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1852166 0.84 MAPT (0.66) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL4972639 0.82 CYP1A2 (0.72) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL1853814 0.81 MAPT (0.67) MAPTALDH1A1KMT2AGAAMEN1
SCHEMBL19988167 0.81 CA12 (0.65) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL29992948 0.79 ALDH1A1 (0.58) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL12005896 0.79 ALDH1A1 (0.57) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL4162660 0.79 F2 (0.46) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL28106923 0.79 RAB9A (0.70) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL20914551 0.78 NPC1 (0.49) MAPTALDH1A1KDM4EKMT2AGAA
SCHEMBL3994082 0.77 KDM4E (0.61) MAPTALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467992-B1 ANTIMICROBIAL DIHYDROTHIAZINE AND DIHYDROTHIOPYRAN OXAZOLIDINONES PHARMACIA & UPJOHN CO LLC (US) 2007-08-08 EP disclosed
US-7101874-B2 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA AND UPJOHN COMPANY (US) 2006-09-05 US disclosed
US-20050143376-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones GORDEEV MIKHAIL F (US) 2005-06-30 US disclosed
US-6884813-B2 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA & UPJOHN COMPANY (US) 2005-04-26 US disclosed
EP-1467992-A1 ANTIMICROBIAL DIHYDROTHIAZINE AND DIHYDROTHIOPYRAN OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 2004-10-20 EP disclosed
US-20030232812-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones PHARMACIA & UPJOHN COMPANY 2003-12-18 US disclosed
WO-2003062231-A1 ANTIMICROBIAL DIHYDROTHIAZINE AND DIHYDROTHIOPYRAN OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143376-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones DHX35, DHX15, OXA1L MAPT 3329/4885ALDH1A1 802/4885KDM4E 2545/4885
US-20030232812-A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones DHX35, ZYX, DHX15 MAPT 3524/4885ALDH1A1 714/4885KDM4E 2629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.